Patents by Inventor Thangeswaran Ramar

Thangeswaran Ramar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prodrugs in the modulation of interleukin
    Patent number: 12528782
    Abstract: There are disclosed prodrugs of the compounds of the formula. The prodrugs are useful in the modulation of IL-12, IL-23 and/or IFN?, by acting on Tyk-2 to cause signal transduction inhibition.
    Type: Grant
    Filed: July 14, 2020
    Date of Patent: January 20, 2026
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ryan M. Moslin, David S. Weinstein, Thangeswaran Ramar, Murugaiah Andappan Murugaiah Subbaiah
  • PRODRUGS IN THE MODULATION OF INTERLEUKIN
    Publication number: 20230167082
    Abstract: There are disclosed prodrugs of the compounds of the formula. The prodrugs are useful in the modulation of IL-12, IL-23 and/or IFN?, by acting on Tyk-2 to cause signal transduction inhibition.
    Type: Application
    Filed: July 14, 2020
    Publication date: June 1, 2023
    Inventors: Ryan M. Moslin, David S. Weinstein, Thangeswaran Ramar, Murugaiah Andappan Murugaiah Subbaiah